Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-02-06 @ 12:49 PM
Study NCT ID:
NCT03273595
Status:
UNKNOWN
Last Update Posted:
2017-09-06
First Post:
2017-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07
Start Date Type:
None
Primary Completion Date:
2019-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-22
First Submit QC Date:
None
Study First Post Date:
2017-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-04
Last Update Post Date:
2017-09-06
Last Update Post Date Type:
ACTUAL